We only have this paper's title and publication details.
Read it at the sourceTMAO aggravates liver steatosis by suppressing BA-mediated hepatic FXR signaling.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: